Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension

Journal of Cardiovascular Pharmacology

Volumn 12, Issue 1, 1988, Pages 88-93

  Säynävälammi, Pekka ^a   Pörsti, Ilkka ^a   Pörsti, Pauli ^a   Nurmi, Anna Kaisa ^a   Seppälä, Erkki ^a   Manninen, Vesa ^b   Vapaatalo, Heikki ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Angiotensin; Angiotensin converting enzyme inhibitor; Blood pressure; Essential hypertension; Prostanoids; Quinapril

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; PROSTAGLANDIN; QUINAPRIL;

BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME BLOOD LEVEL; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CLINICAL TRIALS; FEMALE; HUMAN; HYPERTENSION; ISOQUINOLINES; MALE; MIDDLE AGE; PROSTAGLANDINS; RENIN-ANGIOTENSIN SYSTEM;

EID: 0023908334     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-198807000-00012     Document Type: Article

References (31)

1. Antonaccio MJ. Angiotensin converting enzyme (ACE) inhibitors. Ann Rev Pharmacol Toxicol 1982;22:57-87.
2. Zusman RM. Renin- and non-renin-mediated antihypertensive actions of converting enzyme inhibitors. Kidnev Int 1984;25:969-83.
3. Todd PA, Heel RC. Enalapril: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs 1986;31:198-248.
4. Abe K, Ito T, Sato M, et al. Role of prostaglandins in the antihypertensive mechanism of captopril in low renin hypertension. Clin Sci 1980;59:141S-4S.
5. Fujita T, Yamashita N, Yamashita K. Effect of indomethacin on antihypertensive action of captopril in hypertensive patients. Clin Exp Hypertension 1981;3:939-52.
6. Swartz SL, Williams GH. Angiotensin-converting enzyme inhibition and prostaglandins. Am J Cardiol 1982;49:1405-9.
7. Säynävälammi P. Effects of captopril on the urinary excretion of prostanoids and kallikrein in spontaneously hypertensive rats. Acta Pharmacol Toxicol 1986;59:285-90.
8. Usberti M, Di Minno G, Ungaro B, et al. Angiotensin II inhibition with captopril on plasma ADH. PG synthesis, and renal function in humans. Am J Physiol 1986;250:F986-90.
9. Kaplan HR, Cohen DM, Essenburg AD, Major TC, Mertz TE, Ryan MJ. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors. Fed Proc 1984;43:1326-9.
10. Cohen DM, Evans DB, Ryan MJ, Kaplan HR. Quinapril. In: Scriabine A, ed. New drugs annual: cardiovascular drugs. New York: Raven Press. 1985:71-84.
11. Ryan MJ, Boucher DM, Cohen DM, et al. Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907. Fed Proc 1984;43:1330-2.
12. Säynävälammi P, Pörsti I, Nurmi A-K, et al. Inhibition of angiotensin-converting enzyme with quinapril (CI-906): investigation of antihypertensive mechanisms in spontaneously hypertensive rats. J Pharmacol Exp Ther 1986;237:246-51.
13. Gavras I, Vlahakos D, Melby JC, Gavras H. Pilot study of the effects of the angiotensin-converting enzyme inhibitor CI-906 on patients with essential hypertension. J Clin Pharmacol 1984;24:343-50.
14. Investigator's Brochure. Warner-Lambert/Parke-Davis Co. Ann Arbor, Michigan. 1986.
15. Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 1971;20:1637-48.
16. Lieberman J. Elevation of serum angiotensin-converting enzyme (ACE) level in sarcoidosis. Am J Med 1975;59:365-72.
17. Freedlender AE, Fyhrquist F, Hallemans HJG. Renin and the angiotensins. In: Behrson S, Jaffe B, eds. Methods of hormone radioimmunoassay. New York: Academic Press, 1974:455-69.
18. Nussberger J, Re R, Matsueda GR, Haber E. A simplified radioimmunoassay for physiologically active angiotensin peptides [(1-8) octa- and (2-8) heptapeptides]. Horm Metahol Res 1984;16:606-10.
19. Seppälä E, Pora O, Metsä-Ketelä T. A modified method for extraction and purification of prostaglandins with resin XAD-2. Prostaglandins Leukotr Med 1984;14:235-41.
20. Riutta A, Seppälä E, Vapaatalo H. A rapid and sensitive method for detecting different arachidonic acid metabolites by thin-layer chromatography: the use of autoradiography. J Chromatogr 1984;307:185-9.
21. Edwards CRW, Padfield PL. Angiotensin-converting enzyme inhibitors: past, present, and bright future. Lancet 1985;1:30-4.
22. Lijnen P, Verschueren LJ, Fagard R, Staessen J, Amery A. Acute changes in the renin-angiotensin-aldosterone system, catecholamines and prostaglandins during captopril in man. Meth Find Exp Clin Pharmacol 1980;2:293-301.
23. 2 metabolites after angiotensin converting enzyme inhibition in hypertensive patients. Prostaglandins Leukotr Med 1983;11:143-50.
24. Hosoki K, Takeyama K, Minato H, Fukuya F, Kawahara S, Kadokawa T. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals. Arzneim-Forsch/Drug Res 1986;36:77-83.
25. Sherf H, Pietsch R, Landsberg G, Kramer HJ, Dilsing R. Converting enzyme inhibitor ramipril stimulates prostacyclin synthesis by isolated rat aorta: evidence for a kinin-dependent mechanism. Klin Wochenschr 1986;64:742-5.
26. Durao V, Prata MM, Goncalves LMP. Modification of antihypertensive effect of β-adrenoceptor-blocking agents by inhibition of endogenous prostaglandin synthesis. Lancet 1977;2:1005-7.
27. Watkins J, Abbot EC, Hensby CN, Webster J, Dollery CT. Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. Br Med J 1980;281:702-5.
28. Wing LMH, Bune ACJ, Chalmers JP, Graham JR, West MJ. The effects of indomethacin in treated hypertensive patients. Clin Exp Pharmacol Physiol 1981;8:537-41.
29. Ylitalo P, Pitkäjärvi T, Pyykönen M-L, Nurmi A-K, Seppälä E, Vapaatalo H. Inhibition of prostaglandin synthesis by indomethacin interacts with the antihypertensive effect of atenolol. Clin Pharmacol Ther 1985;38:443-9.
30. Pörsti I, Säynävälammi P, Arvola P, et al. Effects of two structurally different angiotensin-converting enzyme inhibitors, captopril and quinapril (Cl-906), in rats with one-kidney deoxycorticosterone-salt hypertension. Meth Find Exp Clin Pharmacol 1986;8:543-6.
31. Säynävälammi P, Pörsti I. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system. Meth Find Exp Clin Pharmacol 1987;9:325-31.